The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease

BACKGROUND: There is growing interest in identifying sensitive composite cognitive tests to serve as primary endpoints in preclinical Alzheimer’s disease (AD) treatment trials. We reported previously a composite cognitive test score sensitive to tracking preclinical AD decline up to 5 years prior to...

Descripción completa

Detalles Bibliográficos
Autores principales: Langbaum, Jessica B., Ellison, Noel N., Caputo, Angelika, Thomas, Ronald G., Langlois, Carolyn, Riviere, Marie-Emmanuelle, Graf, Ana, Lopez Lopez, Cristina, Reiman, Eric M., Tariot, Pierre N., Hendrix, Suzanne B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254761/
https://www.ncbi.nlm.nih.gov/pubmed/32460855
http://dx.doi.org/10.1186/s13195-020-00633-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254761/
https://www.ncbi.nlm.nih.gov/pubmed/32460855
http://dx.doi.org/10.1186/s13195-020-00633-2

Ejemplares similares